Zura Bio Ltd (ZURA): Insider Trading, Congress Trades & Research | Tormere

ZURA

$4.02+0.75%visit website

Zura Bio Ltd

Market Cap

$387M

Live price × SEC shares (Oct 27, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

-0.27

43mo monthly vs SPY

P/E (TTM)

N/M

TTM to Sep 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

2.2

Mkt cap / shareholders' equity

Flagged input, hover for details

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	Q3 FY2026 Sep 30, 2026	TTM Sep 30, 2026
Research & development	10,956	14,746	20,706	19,491	65,899
Total operating expenses	18,411	25,499	29,321	28,773	102,004
Operating income	(18,411)	(25,499)	(29,321)	(28,773)	(102,004)
Pretax income	(17,175)	(24,223)	(26,385)	(27,046)	(94,829)
Income tax		0	(81)	(1,221)
Net income	(17,175)	(24,223)	(26,304)	(25,825)	(93,527)
EPS (basic) ($)		(0.22)	(0.21)	(0.20)	(1.11)
EPS (diluted) ($)		(0.22)	(0.21)	(0.20)	(1.11)
Weighted avg. shares (basic)		112,223	126,804	127,713
Weighted avg. shares (diluted)		112,223	126,804	127,713

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Oct 27, 2026, period ended Sep 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 17 more quarters, back to Q2 FY2021, with Tormere Pro.

Signals

Insider Velocity

no recent activity

purchases / sales, 90d

Market & Alt Data

News

15

recent articles

Analyst Consensus

Strong Buy

14 analysts

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-02-26	2026-03-02	AI Biotechnology LLC	10% Owner	Purchase	2.00M	$6.25	$12.50M	6.55M	View

Recent News

Zura Bio Ltd SEC Filing (Nov 4, 2026)

Stock Titan · 2026-11-04

Zura Bio (ZURA) Stock Forecast & Analyst Ratings

Moomoo · 2026-11-02

Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Yahoo · 2026-10-27

Zura Bio Files Prospectus To Offer Up To $700M Of Securities

Benzinga · 2026-10-27

12 Health Care Stocks Moving In Tuesday's Intraday Session

Benzinga · 2026-10-27

Zura Bio Reports Third Quarter 2026 Financial Results and Recent Corporate Updates

Yahoo · 2026-10-27

Zura Bio Q3 EPS $(0.20), Inline

Benzinga · 2026-10-27

These stocks have an unusual volume in today's session

ChartMill · 2026-10-14

BKV, Lamb Weston, Penguin Solutions And Other Big Stocks Moving Higher On Wednesday

Benzinga · 2026-10-07

This biotech stock is a top pick at Guggenheim

Yahoo · 2026-10-07

Zura Bio (ZURA) Hits Enrollment Milestones As Losses Widen Sharply

Yahoo Finance · 2026-09-11

Zura Bio to Participate in the Cantor Global Healthcare Conference

Yahoo Finance · 2026-08-31

Zura Bio Stock Draws Bullish Targets As Tibulizumab Momentum Builds

Timothy Sykes · 2026-08-24

Guggenheim raises Zura Bio stock price target on new drug indication

Investing.com · 2026-08-12

Zura Bio Limited Stock 12‑Month Price Target Raised to $18.83, Implies 235% Upside

TradingView · 2026-08-11

Informational purposes only, not investment advice.